Emthexate: Clinical Trials

96 trials of Emthexate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed, 20 active not recruiting, 16 recruiting, 7 terminated. 61 Phase 2, 27 Phase 3, 22 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 261Completed 20, Recruiting 13, Active not recruiting 10, Terminated 7, Withdrawn 4, Not yet recruiting 3, Unknown 3, Suspended 1
Phase 327Completed 14, Active not recruiting 7, Recruiting 3, Not yet recruiting 2, Suspended 1
Phase 122Completed 8, Terminated 4, Active not recruiting 3, Unknown 3, Withdrawn 2, Not yet recruiting 1, Recruiting 1

Follow Emthexate: new trials by email Literature Review of Emthexate trials Research Report on Emthexate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Asciminib, Biospecimen Collection, Blinatumomab - B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1Not yet recruitingCity of Hope Medical Center212027-10-132026-11-03
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Carboplatin - Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Phase 2 / Phase 3Not yet recruitingNational Cancer Institute (NCI)2712026-10-302026-08-19
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingSWOG Cancer Research Network902026-10-142026-10-13
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1WithdrawnChildren's Oncology Group2026-09-102026-05-05
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082026-08-282026-07-30
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Ruxolitinib, Allogeneic Hematopoietic Stem Cell Transplantation, Busulfan - Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis
Phase 2RecruitingFred Hutchinson Cancer Center502026-02-042026-10-19
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma
Phase 2RecruitingCity of Hope Medical Center532025-10-102026-10-13
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Celecoxib, Erlotinib Hydrochloride, Imaging Procedure - Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma
Phase 2RecruitingMayo Clinic252025-08-072026-10-01
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)1532025-06-052026-10-27
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
Biospecimen Collection, Cytarabine, Lumbar Puncture - Hematopoietic and Lymphatic System Neoplasm
Phase 2RecruitingOHSU Knight Cancer Institute262025-06-042026-11-10
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy - B Acute Lymphoblastic Leukemia
Phase 2RecruitingNational Cancer Institute (NCI)2222025-05-302026-10-27
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Myelodysplastic Syndrome
Phase 1RecruitingChildren's Oncology Group362025-02-042026-08-25
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
Phase 2WithdrawnNational Cancer Institute (NCI)2024-08-092024-05-17
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Biospecimen Collection, Chest Computed Tomography, Echocardiography - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 2RecruitingCity of Hope Medical Center402024-08-012026-10-14
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Calaspargase Pegol - Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia
Phase 2Active not recruitingChildren's Oncology Group782024-01-082026-08-25
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat
Anti-CD123 ADC IMGN632, Bone Marrow Aspiration and Biopsy, Cytarabine - Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia
Phase 1 / Phase 2WithdrawnChildren's Oncology Group2023-08-012023-09-01
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Aspiration, Busulfan - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 3Active not recruitingChildren's Oncology Group662023-03-152026-07-30
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)11222023-03-032026-10-27
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
Dasatinib, Methotrexate, Prednisone - B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1Active not recruitingOHSU Knight Cancer Institute202022-09-022026-05-06
Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride - B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia
Phase 1Active not recruitingCity of Hope Medical Center242022-03-172026-05-28

Showing 20 of 96. Sign in to see all of them.

Conditions studied

Burkitt Lymphoma (31)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (29)  ·  Leukemia, Biphenotypic, Acute (14)  ·  Leukemia, Myeloid, Acute (12)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (11)  ·  Blast Crisis (6)  ·  Myelodysplastic Syndromes (6)  ·  Leukemia, Myeloid, Accelerated Phase (5)  ·  Lymphoma, Mantle-Cell (5)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (5)  ·  Hematologic Neoplasms (4)  ·  Primary Myelofibrosis (4)  ·  Blastic Plasmacytoid Dendritic Cell Neoplasm (3)  ·  Down Syndrome (3)  ·  Anemia, Refractory, with Excess of Blasts (2)

Sponsors

National Cancer Institute (NCI) (24)  ·  Children's Oncology Group (22)  ·  M.D. Anderson Cancer Center (22)  ·  Fred Hutchinson Cancer Center (8)  ·  OHSU Knight Cancer Institute (5)  ·  City of Hope Medical Center (4)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Dokuz Eylul University (1)  ·  GOG Foundation (1)  ·  Gynecologic Oncology Group (1)  ·  Mayo Clinic (1)  ·  Northwestern University (1)  ·  Radboud University Medical Center (1)  ·  Roswell Park Cancer Institute (1)  ·  SWOG Cancer Research Network (1)

Countries

United States (87)  ·  Canada (29)  ·  Australia (24)  ·  Puerto Rico (19)  ·  New Zealand (14)  ·  Switzerland (7)  ·  Israel (3)  ·  Belgium (2)  ·  Ireland (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Chile (1)  ·  Czechia (1)  ·  Finland (1)  ·  France (1)

Top investigators

Elias Jabbour (8)  ·  Marie Bleakley (3)  ·  Anne L Angiolillo (2)  ·  Farhad Ravandi-Kashani (2)  ·  Ibrahim Aldoss (2)  ·  Issa Khouri (2)  ·  Rachel B. Salit (2)  ·  Alexandra M Stevens (1)  ·  Alvaro J Alencar (1)  ·  Alyssa T Reddy (1)  ·  Andrea Biondi (1)  ·  Anjali S Advani (1)  ·  Barbara Pro, MD (1)  ·  Ben K Watkins (1)

Results publications

PMID 41671463, PMID 35622074, PMID 37890117, PMID 39121442, PMID 26590194, PMID 29284596, PMID 35007144, PMID 36603187, PMID 38446568, PMID 40315406, PMID 42085640, PMID 20466853, PMID 23678006, PMID 24829202, PMID 24970932, PMID 25145344, PMID 25421877, PMID 25624441, PMID 25964296, PMID 26124497, PMID 26265699, PMID 26432046, PMID 27569442, PMID 27903924, PMID 29618479, PMID 29785709, PMID 29812996, PMID 30138085, PMID 30501869, PMID 30626253, PMID 31212080, PMID 31401903, PMID 32414848, PMID 32460997, PMID 32496902, PMID 32552472, PMID 32589970, PMID 32589978, PMID 32730180, PMID 32813610, PMID 33049057, PMID 33191168, PMID 33242441, PMID 33411585, PMID 33496745, PMID 33651090, PMID 33684925, PMID 33843815, PMID 33844429, PMID 34138471

NIH funding

U10CA180886 (26), U10CA098543 (17), P30CA016672 (6), P30CA033572 (4), U10CA180821 (4), U10CA180888 (4), P01CA018029 (3), P30CA015704 (3), U10CA180820 (3), R01HL121568 (2), U10CA027469 (2), U10CA031946 (2), UM1CA228823 (2), 2004 (1), 2017 (1)